Rosetta Molecular Diagnostics Test Menu Expansion

Rosetta Genomics has expanded its molecular diagnostic test menu by launching three new tests: HEME FISH, BRAF Lung, and NRAS Colon:

• HEME FISH contains a portfolio of disease-specific diagnostic, prognostic and predictive test panels for various hematologic malignancies. It uses multiple fluorescence in situ hybridization tests to detect DNA amplifications or rearrangements in a number of hematologic cancers, such as leukemias, lymphomas, and myelomas.
• BRAF Lung is a mutation analysis assay for lung cancer, analyzed using CAST PCR technology.
• NRAS Colon is a mutation analysis assay for colon cancer, also analyzed using CAST PCR technology.

These test expand the company's tumor service offerings through its Lake Forest, CA-based laboratory.